Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecules
1.2.4 Small Molecule Drug Conjugates
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Lymphoma
1.3.3 Melanoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Cancer Therapy Market Perspective (2018-2033)
2.2 Global Small Molecule Targeted Cancer Therapy Growth Trends by Region
2.2.1 Small Molecule Targeted Cancer Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Small Molecule Targeted Cancer Therapy Historic Market Size by Region (2018-2023)
2.2.3 Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2024-2033)
2.3 Small Molecule Targeted Cancer Therapy Market Dynamics
2.3.1 Small Molecule Targeted Cancer Therapy Industry Trends
2.3.2 Small Molecule Targeted Cancer Therapy Market Drivers
2.3.3 Small Molecule Targeted Cancer Therapy Market Challenges
2.3.4 Small Molecule Targeted Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Small Molecule Targeted Cancer Therapy by Players
3.1.1 Global Small Molecule Targeted Cancer Therapy Revenue by Players (2018-2023)
3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Small Molecule Targeted Cancer Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Cancer Therapy Revenue in 2022
3.5 Global Key Players of Small Molecule Targeted Cancer Therapy Head office and Area Served
3.6 Global Key Players of Small Molecule Targeted Cancer Therapy, Product and Application
3.7 Global Key Players of Small Molecule Targeted Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Cancer Therapy Breakdown Data by Type
4.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2018-2023)
4.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2024-2033)
5 Small Molecule Targeted Cancer Therapy Breakdown Data by Application
5.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2018-2023)
5.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2018-2033)
6.2 North America Small Molecule Targeted Cancer Therapy Market Size by Type
6.2.1 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023)
6.2.2 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2024-2033)
6.2.3 North America Small Molecule Targeted Cancer Therapy Market Share by Type (2018-2033)
6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Application
6.3.1 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023)
6.3.2 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2024-2033)
6.3.3 North America Small Molecule Targeted Cancer Therapy Market Share by Application (2018-2033)
6.4 North America Small Molecule Targeted Cancer Therapy Market Size by Country
6.4.1 North America Small Molecule Targeted Cancer Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2023)
6.4.3 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2018-2033)
7.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type
7.2.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023)
7.2.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2024-2033)
7.2.3 Europe Small Molecule Targeted Cancer Therapy Market Share by Type (2018-2033)
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Application
7.3.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023)
7.3.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2024-2033)
7.3.3 Europe Small Molecule Targeted Cancer Therapy Market Share by Application (2018-2033)
7.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Country
7.4.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2023)
7.4.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Small Molecule Targeted Cancer Therapy Market Size (2018-2033)
8.2 China Small Molecule Targeted Cancer Therapy Market Size by Type
8.2.1 China Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023)
8.2.2 China Small Molecule Targeted Cancer Therapy Market Size by Type (2024-2033)
8.2.3 China Small Molecule Targeted Cancer Therapy Market Share by Type (2018-2033)
8.3 China Small Molecule Targeted Cancer Therapy Market Size by Application
8.3.1 China Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023)
8.3.2 China Small Molecule Targeted Cancer Therapy Market Size by Application (2024-2033)
8.3.3 China Small Molecule Targeted Cancer Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Small Molecule Targeted Cancer Therapy Market Size (2018-2033)
9.2 Asia Small Molecule Targeted Cancer Therapy Market Size by Type
9.2.1 Asia Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023)
9.2.2 Asia Small Molecule Targeted Cancer Therapy Market Size by Type (2024-2033)
9.2.3 Asia Small Molecule Targeted Cancer Therapy Market Share by Type (2018-2033)
9.3 Asia Small Molecule Targeted Cancer Therapy Market Size by Application
9.3.1 Asia Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023)
9.3.2 Asia Small Molecule Targeted Cancer Therapy Market Size by Application (2024-2033)
9.3.3 Asia Small Molecule Targeted Cancer Therapy Market Share by Application (2018-2033)
9.4 Asia Small Molecule Targeted Cancer Therapy Market Size by Region
9.4.1 Asia Small Molecule Targeted Cancer Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Small Molecule Targeted Cancer Therapy Market Size by Region (2018-2023)
9.4.3 Asia Small Molecule Targeted Cancer Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Small Molecule Targeted Cancer Therapy Introduction
11.1.4 Roche Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.1.5 Roche Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Small Molecule Targeted Cancer Therapy Introduction
11.2.4 Gilead Sciences Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.2.5 Gilead Sciences Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Introduction
11.3.4 Boehringer Ingelheim Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Introduction
11.4.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.4.5 Abbott Laboratories Recent Developments
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Small Molecule Targeted Cancer Therapy Introduction
11.5.4 Bayer AG Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.5.5 Bayer AG Recent Developments
11.6 GSK
11.6.1 GSK Company Details
11.6.2 GSK Business Overview
11.6.3 GSK Small Molecule Targeted Cancer Therapy Introduction
11.6.4 GSK Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.6.5 GSK Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Small Molecule Targeted Cancer Therapy Introduction
11.7.4 AstraZeneca Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.7.5 AstraZeneca Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Small Molecule Targeted Cancer Therapy Introduction
11.8.4 Johnson & Johnson Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.8.5 Johnson & Johnson Recent Developments
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Small Molecule Targeted Cancer Therapy Introduction
11.9.4 Teva Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.9.5 Teva Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Small Molecule Targeted Cancer Therapy Introduction
11.10.4 Pfizer Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.10.5 Pfizer Recent Developments
11.11 Allergan
11.11.1 Allergan Company Details
11.11.2 Allergan Business Overview
11.11.3 Allergan Small Molecule Targeted Cancer Therapy Introduction
11.11.4 Allergan Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.11.5 Allergan Recent Developments
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Small Molecule Targeted Cancer Therapy Introduction
11.12.4 Merck Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.12.5 Merck Recent Developments
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Small Molecule Targeted Cancer Therapy Introduction
11.13.4 Novartis Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.13.5 Novartis Recent Developments
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Small Molecule Targeted Cancer Therapy Introduction
11.14.4 Sanofi Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.14.5 Sanofi Recent Developments
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Small Molecule Targeted Cancer Therapy Introduction
11.15.4 Amgen Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.15.5 Amgen Recent Developments
11.16 AbbVie
11.16.1 AbbVie Company Details
11.16.2 AbbVie Business Overview
11.16.3 AbbVie Small Molecule Targeted Cancer Therapy Introduction
11.16.4 AbbVie Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.16.5 AbbVie Recent Developments
11.17 Eli Lilly
11.17.1 Eli Lilly Company Details
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly Small Molecule Targeted Cancer Therapy Introduction
11.17.4 Eli Lilly Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023)
11.17.5 Eli Lilly Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small Molecules
Table 4. Key Players of Small Molecule Drug Conjugates
Table 5. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Small Molecule Targeted Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Small Molecule Targeted Cancer Therapy Market Share by Region (2018-2023)
Table 9. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Small Molecule Targeted Cancer Therapy Market Share by Region (2024-2033)
Table 11. Small Molecule Targeted Cancer Therapy Market Trends
Table 12. Small Molecule Targeted Cancer Therapy Market Drivers
Table 13. Small Molecule Targeted Cancer Therapy Market Challenges
Table 14. Small Molecule Targeted Cancer Therapy Market Restraints
Table 15. Global Small Molecule Targeted Cancer Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Small Molecule Targeted Cancer Therapy Revenue Share by Players (2018-2023)
Table 17. Global Top Small Molecule Targeted Cancer Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2022)
Table 18. Global Small Molecule Targeted Cancer Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Small Molecule Targeted Cancer Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Small Molecule Targeted Cancer Therapy, Headquarters and Area Served
Table 21. Global Key Players of Small Molecule Targeted Cancer Therapy, Product and Application
Table 22. Global Key Players of Small Molecule Targeted Cancer Therapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2024-2033)
Table 28. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Small Molecule Targeted Cancer Therapy Revenue Share by Application (2018-2023)
Table 30. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Small Molecule Targeted Cancer Therapy Revenue Share by Application (2024-2033)
Table 32. North America Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Small Molecule Targeted Cancer Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Small Molecule Targeted Cancer Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Small Molecule Targeted Cancer Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Small Molecule Targeted Cancer Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Small Molecule Targeted Cancer Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Small Molecule Targeted Cancer Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Small Molecule Targeted Cancer Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Small Molecule Targeted Cancer Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Small Molecule Targeted Cancer Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Small Molecule Targeted Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Small Molecule Targeted Cancer Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Small Molecule Targeted Cancer Therapy Product
Table 67. Roche Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 68. Roche Recent Developments
Table 69. Gilead Sciences Company Details
Table 70. Gilead Sciences Business Overview
Table 71. Gilead Sciences Small Molecule Targeted Cancer Therapy Product
Table 72. Gilead Sciences Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 73. Gilead Sciences Recent Developments
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Product
Table 77. Boehringer Ingelheim Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Developments
Table 79. Abbott Laboratories Company Details
Table 80. Abbott Laboratories Business Overview
Table 81. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product
Table 82. Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 83. Abbott Laboratories Recent Developments
Table 84. Bayer AG Company Details
Table 85. Bayer AG Business Overview
Table 86. Bayer AG Small Molecule Targeted Cancer Therapy Product
Table 87. Bayer AG Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 88. Bayer AG Recent Developments
Table 89. GSK Company Details
Table 90. GSK Business Overview
Table 91. GSK Small Molecule Targeted Cancer Therapy Product
Table 92. GSK Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 93. GSK Recent Developments
Table 94. AstraZeneca Company Details
Table 95. AstraZeneca Business Overview
Table 96. AstraZeneca Small Molecule Targeted Cancer Therapy Product
Table 97. AstraZeneca Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 98. AstraZeneca Recent Developments
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Small Molecule Targeted Cancer Therapy Product
Table 102. Johnson & Johnson Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 103. Johnson & Johnson Recent Developments
Table 104. Teva Company Details
Table 105. Teva Business Overview
Table 106. Teva Small Molecule Targeted Cancer Therapy Product
Table 107. Teva Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 108. Teva Recent Developments
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Small Molecule Targeted Cancer Therapy Product
Table 112. Pfizer Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 113. Pfizer Recent Developments
Table 114. Allergan Company Details
Table 115. Allergan Business Overview
Table 116. Allergan Small Molecule Targeted Cancer Therapy Product
Table 117. Allergan Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 118. Allergan Recent Developments
Table 119. Merck Company Details
Table 120. Merck Business Overview
Table 121. Merck Small Molecule Targeted Cancer Therapy Product
Table 122. Merck Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 123. Merck Recent Developments
Table 124. Novartis Company Details
Table 125. Novartis Business Overview
Table 126. Novartis Small Molecule Targeted Cancer Therapy Product
Table 127. Novartis Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 128. Novartis Recent Developments
Table 129. Sanofi Company Details
Table 130. Sanofi Business Overview
Table 131. Sanofi Small Molecule Targeted Cancer Therapy Product
Table 132. Sanofi Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 133. Sanofi Recent Developments
Table 134. Amgen Company Details
Table 135. Amgen Business Overview
Table 136. Amgen Small Molecule Targeted Cancer Therapy Product
Table 137. Amgen Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 138. Amgen Recent Developments
Table 139. AbbVie Company Details
Table 140. AbbVie Business Overview
Table 141. AbbVie Small Molecule Targeted Cancer Therapy Product
Table 142. AbbVie Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 143. AbbVie Recent Developments
Table 144. Eli Lilly Company Details
Table 145. Eli Lilly Business Overview
Table 146. Eli Lilly Small Molecule Targeted Cancer Therapy Product
Table 147. Eli Lilly Revenue in Small Molecule Targeted Cancer Therapy Business (2018-2023) & (US$ Million)
Table 148. Eli Lilly Recent Developments
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Small Molecule Targeted Cancer Therapy Market Share by Type: 2022 VS 2033
Figure 3. Monoclonal Antibodies Features
Figure 4. Small Molecules Features
Figure 5. Small Molecule Drug Conjugates Features
Figure 6. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2022 VS 2033
Figure 8. Lymphoma Case Studies
Figure 9. Melanoma Case Studies
Figure 10. Multiple Myeloma Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Prostate Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Small Molecule Targeted Cancer Therapy Report Years Considered
Figure 15. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Small Molecule Targeted Cancer Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Small Molecule Targeted Cancer Therapy Market Share by Region: 2022 VS 2033
Figure 18. Global Small Molecule Targeted Cancer Therapy Market Share by Players in 2022
Figure 19. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2022
Figure 21. North America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Small Molecule Targeted Cancer Therapy Market Share by Type (2018-2033)
Figure 23. North America Small Molecule Targeted Cancer Therapy Market Share by Application (2018-2033)
Figure 24. North America Small Molecule Targeted Cancer Therapy Market Share by Country (2018-2033)
Figure 25. United States Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Small Molecule Targeted Cancer Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Small Molecule Targeted Cancer Therapy Market Share by Type (2018-2033)
Figure 29. Europe Small Molecule Targeted Cancer Therapy Market Share by Application (2018-2033)
Figure 30. Europe Small Molecule Targeted Cancer Therapy Market Share by Country (2018-2033)
Figure 31. Germany Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Small Molecule Targeted Cancer Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Small Molecule Targeted Cancer Therapy Market Share by Type (2018-2033)
Figure 39. China Small Molecule Targeted Cancer Therapy Market Share by Application (2018-2033)
Figure 40. Asia Small Molecule Targeted Cancer Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Small Molecule Targeted Cancer Therapy Market Share by Type (2018-2033)
Figure 42. Asia Small Molecule Targeted Cancer Therapy Market Share by Application (2018-2033)
Figure 43. Asia Small Molecule Targeted Cancer Therapy Market Share by Region (2018-2033)
Figure 44. Japan Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Small Molecule Targeted Cancer Therapy Market Share by Country (2018-2033)
Figure 54. Brazil Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 61. Gilead Sciences Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 63. Abbott Laboratories Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 64. Bayer AG Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 65. GSK Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 66. AstraZeneca Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 67. Johnson & Johnson Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 68. Teva Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 69. Pfizer Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 70. Allergan Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 71. Merck Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 72. Novartis Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 73. Sanofi Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 74. Amgen Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 75. AbbVie Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 76. Eli Lilly Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2018-2023)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed